Generate a tailored SOP for Dr. Malaka Ameratunga. Improve your application with a focused, well-structured draft.
Malaka Ameratunga is a clinical medical oncologist and research fellow at Monash University with a specialized focus in neuro-oncology and early phase clinical trials. With a foundational education including an MBBS and FRACP, he has made substantial contributions to the field through 27 peer-reviewed publications, including significant works as both first and senior author. His research has notably addressed clinical correlates of PD-L1 immunohistochemistry in non-small cell lung cancer, and he has conducted a Cochrane meta-analysis on anti-angiogenic therapy in glioblastoma. Ameratunga's expertise extends to developing novel therapeutic approaches for rare brain tumors, and he has played a pivotal role in early drug development, having authored the first-in-human study of a novel BET inhibitor. He also contributed to identifying clinically relevant biomarkers for early-phase trials and has established several international collaborations. He completed a two-year fellowship focusing on drug development at the Institute of Cancer Research and the Royal Marsden Hospital under Professor Johann de Bono. Currently, Ameratunga manages neuro-oncology patients at the Alfred Hospital and continues to work on various active research projects.
Monash University • Melbourne, VIC, Australia
Engaged in advanced clinical research in neuro-oncology and early phase clinical trials.
Alfred Hospital • Melbourne, VIC, Australia
Provides clinical care for neuro-oncology patients.
Cabrini Health Limited • Melbourne, VIC, Australia
Involved in providing oncology services.
Requirements are standardized across the Faculty of Information Technology for most Master's programs including Computer Science and Data Science.